|
GB202010970D0
|
|
Methods, arrays and uses thereof
|
|
GB201904472D0
|
|
Methods, arrays and uses thereof
|
|
JP2019032334A
|
|
Method for determining breast cancer-related disease state, and array to be used in the method
|
|
GB201801481D0
|
|
Methods, conjugates and systems
|
|
GB201701572D0
|
|
Methods, arrays and uses thereof
|
|
GB201609951D0
|
|
Biomarkers signatures and uses thereof
|
|
GB201609950D0
|
|
Biomarkers signatures and uses thereof
|
|
GB201608192D0
|
|
Method, array and use thereof
|
|
GB201516801D0
|
|
Method, array and use thereof
|
|
GB201410226D0
|
|
Methods and arrays for use in the same
|
|
GB201319878D0
|
|
Method, Array and use thereof
|
|
GB201305940D0
|
|
Methods and arrays for use in the same
|
|
GB201206323D0
|
|
Methods and arrays for use in the same
|
|
GB201103726D0
|
|
Method, array and use thereof
|
|
GB201014837D0
|
|
Biomarker signatures and uses thereof
|
|
GB201009798D0
|
|
Method,array and use thereof
|
|
GB0910620D0
|
|
Agents and uses thereof
|
|
GB0815846D0
|
|
diagnosis, prognosis and imaging of disease
|
|
WO2008139169A1
|
|
Sox11 expression in malignant lymphomas
|
|
GB0723179D0
|
|
Diagnostic methods and arrays for use in the same
|
